Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction | NEJM
Original Article from The New England Journal of Medicine — Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Related Articles
Sen. Hickenlooper to visit CU Anschutz Cancer Center in Aurora, discuss possible medical research funding cuts
Sen. John Hickenlooper will tour the CU Anschutz Cancer Lab in Aurora and discuss the impacts of the Trump administration’s decision to cut billions of…
Mass General Brigham will spend $400 million on cancer care in wake of layoffs
Mass General Brigham said it will invest $400 million on cancer care, not long after announcing layoffs.
WIN Consortium revolutionizing precision oncology for cancer patients
A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine:…
Mass General Brigham to invest $400 million to open new cancer institute before Dana-Farber partnership ends – The Boston Globe
The renovations at the state’s biggest health system will help create the Mass General Brigham Cancer Institute.
Prevention and screening drive drop in cancer deaths
Most deaths avoided from common cancers between 1975 and 2020 could be traced to prevention and screening efforts.
Books that mattered to me this year – The Cancer Letter
Over the past year, I noticed several books written by giants in our field, people everyone knows, people I am honored to know personally. I…
Why Don’t U.S. Guidelines Recommend DPYD Testing Before Chemotherapy?
If a person carries a mutation in the DPYD gene, certain chemotherapies, including fluorouracil (5-FU) or capecitabine (Xeloda or CAPE), may make them ill or…
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients
Chen et al. propose a mechanism accounting for the abscopal effects of radiotherapy on distal non-irradiated cancer lesions under immunotherapy. In eight retrospective studies and a…
Governor promises investment for University of Missouri’s cancer treatment development
As federal and state governments look for ways to save money, there is one project Missouri sees fit for extra investments: cancer treatments.